MFDS approves 668 clinical trials with Hanmi Pharm acquired most 11 approvals

Published: 2018-03-26 10:26:56

Updated: 2018-03-26 10:26:56

The Ministry of Food and Drug Safety(Minister Young-Jin Ryu, MFDS) analyzed approval of clinical trial plans in 2017, and the analysis result showed the number of approvals was 658 cases increased by 4.8% from the 2016’s 628 cases and a Korean pharmaceutical company which acquired the most approvals was Hanmi Pharm with 11 cases.

Moreover, the ministry explained approvals of multiregional Phas...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.